Home » Alcon Slapped With Untitled Letter, FDA: Rebate Card Used Incorrectly
Alcon Slapped With Untitled Letter, FDA: Rebate Card Used Incorrectly
The FDA has sent an untitled letter to Novartis subsidiary Alcon Research for a rebate card that the company wrongly treated as reminder labeling.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
07May
-
14May
-
30May